Latest Breaking News On - John saia - Page 1 : comparemela.com

Posted on 465 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today filed a lawsuit against Natera, Inc. for false advertising, unfair competition, and unlawful trade practices, relating to misleading statements Natera has made about its own products and the performance of Guardant Health’s new oncology test, Guardant Reveal™. Guardant Health asked the federal court in San Francisco, California for an injunction preventing Natera from continuing to make these false or misleading statements and requiring Natera to take corrective actions. Guardant Health’s recent introduction of Guardant Reveal™, the first blood-only liquid biopsy test to detect residual and recurrent disease in early-stage cancer survivors, represents an important medical breakthrough for the 1.5 million early-stage colorectal cancer survivors in the U.S.

United statesSan franciscoNatera signateraCarrie mendivilExchange commissionNatera incCenters for diseaseGuardant health incGuardant healthAmerican cancer societyGuardant revealJohn saiaSenior vice presidentGeneral counselCorporate secretaryAnnual report